MedPath

An interventional study for verifying recognition-improving effects by ingesting a whole egg

Not Applicable
Conditions
Healthy male/female adults
Registration Number
JPRN-UMIN000045684
Lead Sponsor
CPCC Company Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Volunteers who take steadily (not less than three times a week) in the health-specific/functional/supplementary/health foods, which might affect the test results. (2) Volunteers who have taken affecting medicines (e.g., antibiotic/gut/laxative regulation), and have any difficulty in refraining from taking them during this study. (3) Volunteers being under medical treatment for dyslipidemia, after diagnosis. (4) Volunteers being under medical treatment for dementia, after diagnosis. (5) Volunteers who take excessive alcohol. (6) Volunteers having extremely irregular eating habits, and irregular life rhythms. (7) Volunteers who have a habit of daily vigorous exercises. (8) Volunteers who take not less than fourteen eggs in their daily life. (9) Volunteers who have previous/current medical history of severe cardiac, hepatic, renal or digestive diseases. (10) Pregnant, possibly pregnant, and lactating women. (11) Volunteers having drug and/or food allergy (especially to egg and wheat). (12) Volunteers who are now under another clinical test with some kind of medicine and/or health food, or took part in that within four weeks before this study, or will participate in that after giving informed consent to take part in this study. (13) Volunteers who donated their blood components and/or whole blood (200 mL) within a month to this trial. (14) Volunteers who donated their whole blood (400 mL) within the last three months to this trial. (15) Volunteers who will be collected in total of their blood (1200 mL) within the last twelve months, after adding the blood amounts planning to be sampled in this study. (16) Others who have been determined as ineligible for participation, according to the principal investigator's opinion.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath